Pain-Relieving Effectiveness of Co-Treatment with Local Tramadol and Systemic Minocycline in Carrageenan-Induced Inflammatory Pain Model
In this study, we tested our working hypothesis that inhibiting the activation of microglia by systemic minocycline treatments can decrease the dosage of local tramadol injection in inflammatory pain. This study was therefore aimed to evaluate the actions of intraplantarly injected tramadol, intraperitoneally injected minocycline, or their combined treatments on the inflammation-induced hypernociception (thermal hyperalgesia, mechanical allodynia), edema, and pro- and anti-inflammatory cytokine levels of paw and spinal cord tissues in a rat model of carrageenan-induced hindpaw inflammation. While local tramadol or systemic minocycline caused a significant anti-hypernociceptive effect their combined treatments significantly enhanced anti-hypernociceptive action compared to each agent applied alone. Also anti-edematous actions of combined treatment were higher than that of their individual administrations. In addition, combined treatment significantly decreased the level of the pro-inflammatory cytokines and caused significant increases in anti-inflammatory cytokine level of paw and spinal cord tissues. The present finding can suggest that combined treatments of local tramadol and systemic minocycline may decrease the dose requirements for anti-hypernociceptive actions of local tramadol and this combination therapy might be a beneficial option for the inflammatory pain relief.
KEY WORDSminocycline tramadol inflammation cytokines rat
We acknowledge the support given by Kahramanmaras Sutcu Imam University Research Foundation (2016/3-54M) and Scientific and Technical Research Council of Turkey (106S502).
Compliance with ethical standards
Conflict of Interest
The authors state no conflict of interest.
- 8.Raffa, R.B., E. Friderichs, W. Reimann, R.P. Shank, E.E. Codd, and J.L. Vaught. 1992. Opioid and non opioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. Journal of Pharmacology and Experimental Therapeutics 260: 275–278.PubMedGoogle Scholar
- 18.Nasseri, B., V. Nazemian, H. Manaheji, Z. Mousavi, and J. Zaringhalam. 2016. Microglia are involved in pain related behaviors during the acute and chronic phases of arthritis inflammation. Journal of Cellular and Molecular Anesthesia 1 (4): 137–145.Google Scholar
- 29.Yeh, Y.C., T.F. Lin, H.C. Chang, W.S. Chan, Y.P. Wang, C.J. Lin, and W.Z. Sun. 2009. Combination of low-dose nalbuphine and morphine in patient-controlled analgesia decreases incidence of opioid-related side effects. Journal of the Formosan Medical Association 108: 548–553.CrossRefPubMedGoogle Scholar
- 33.Moller, B., and P.M. Villiger. 2006. Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases. Journal of Immunopathology 27: 391–408.Google Scholar